DEF 14ASMMTCIK 0001599298
Summit Therapeutics Inc.
Proxy statement (DEF 14A) filed .
Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.
New to the DEF 14A? What it is and how to read oneFiling facts
- Accession number
- 0001599298-23-000085
- Filer
- Summit Therapeutics Inc.
- Ticker
- SMMT
- CIK
- 0001599298
- Form type
- DEF 14A
- Form description
- Proxy statement
- Filed at
- September 19, 2023
- Period of report
- October 12, 2023
- Filing size
- 1.1 MB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Summit Therapeutics Inc.
See all 44 filings from Summit Therapeutics Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1599298/000159929823000085/0001599298-23-000085-index.htm ↗Filer's full EDGAR submission history
EDGAR · Summit Therapeutics Inc. (0001599298) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.